Elanco Japan K.K. (Tokyo, Japan), a division of Elanco Animal Health Inc.(Indiana USA),today announced the launch of GALLIPRANT ®(generic name: grapiprant) in 20 mg and 60 mg tablets for the control of pain and inflammation associated with osteoarthritis in dogs in Japan.
GALLIPRANT®, now on sale by Elanco Animal Health Inc. in more than 20 countries, is recognized as a leading therapeutic for dogs with osteoarthritis. AskAt has licensed the use of grapiprant for animal health to RaQualia Pharma Inc. (Nagoya, Japan) and will receive royalty payments based on sales of the drug in Japan.
For further details, please see the RaQualia home pages.